Lathrop Investment Management Corp acquired a new stake in shares of Eli Lilly And Co (NYSE:LLY) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 1,636 shares of the company’s stock, valued at approximately $212,000.

Several other institutional investors have also recently modified their holdings of LLY. Vanguard Group Inc raised its stake in shares of Eli Lilly And Co by 0.7% during the third quarter. Vanguard Group Inc now owns 74,132,985 shares of the company’s stock valued at $7,955,211,000 after acquiring an additional 511,752 shares in the last quarter. BlackRock Inc. increased its holdings in Eli Lilly And Co by 3.0% during the fourth quarter. BlackRock Inc. now owns 68,956,519 shares of the company’s stock valued at $7,979,649,000 after buying an additional 2,030,845 shares during the period. Oregon Public Employees Retirement Fund increased its holdings in Eli Lilly And Co by 17,720.8% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 42,420,406 shares of the company’s stock valued at $367,000 after buying an additional 42,182,367 shares during the period. FMR LLC increased its holdings in Eli Lilly And Co by 83.9% during the fourth quarter. FMR LLC now owns 13,687,081 shares of the company’s stock valued at $1,583,870,000 after buying an additional 6,242,865 shares during the period. Finally, Geode Capital Management LLC increased its holdings in Eli Lilly And Co by 6.8% during the fourth quarter. Geode Capital Management LLC now owns 13,108,002 shares of the company’s stock valued at $1,514,582,000 after buying an additional 830,689 shares during the period. Hedge funds and other institutional investors own 79.52% of the company’s stock.

Shares of Eli Lilly And Co stock opened at $118.00 on Thursday. Eli Lilly And Co has a fifty-two week low of $77.09 and a fifty-two week high of $132.13. The stock has a market capitalization of $121.70 billion, a price-to-earnings ratio of 21.26, a PEG ratio of 2.23 and a beta of 0.33. The company has a debt-to-equity ratio of 1.07, a current ratio of 1.73 and a quick ratio of 1.38.

Eli Lilly And Co (NYSE:LLY) last posted its quarterly earnings results on Wednesday, February 6th. The company reported $1.33 earnings per share for the quarter, missing the consensus estimate of $1.36 by ($0.03). Eli Lilly And Co had a net margin of 13.16% and a return on equity of 44.66%. The firm had revenue of $6.44 billion during the quarter, compared to analysts’ expectations of $6.28 billion. During the same period last year, the company earned $1.14 EPS. The business’s quarterly revenue was up 4.5% on a year-over-year basis. On average, sell-side analysts predict that Eli Lilly And Co will post 5.66 earnings per share for the current year.

In other news, insider Donald A. Zakrowski sold 1,000 shares of the stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of $127.01, for a total value of $127,010.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Stephen F. Fry sold 14,847 shares of the stock in a transaction that occurred on Tuesday, March 12th. The shares were sold at an average price of $123.16, for a total transaction of $1,828,556.52. Following the completion of the sale, the senior vice president now directly owns 109,663 shares of the company’s stock, valued at approximately $13,506,095.08. The disclosure for this sale can be found here. In the last three months, insiders sold 867,382 shares of company stock valued at $109,265,182. Corporate insiders own 0.11% of the company’s stock.

Several equities analysts recently issued reports on LLY shares. Cantor Fitzgerald reissued a “buy” rating on shares of Eli Lilly And Co in a report on Monday, February 4th. UBS Group cut their price objective on shares of Eli Lilly And Co from $107.53 to $100.00 and set an “average” rating on the stock in a report on Friday, February 8th. Argus reissued a “buy” rating on shares of Eli Lilly And Co in a report on Thursday, December 27th. Bank of America set a $129.00 price objective on shares of Eli Lilly And Co and gave the company a “hold” rating in a report on Thursday, March 21st. Finally, Citigroup set a $124.00 price objective on shares of Eli Lilly And Co and gave the company a “hold” rating in a report on Tuesday, February 26th. Ten research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $117.89.

WARNING: “Lathrop Investment Management Corp Acquires Shares of 1,636 Eli Lilly And Co (LLY)” was originally published by Watch List News and is the property of of Watch List News. If you are accessing this article on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this article can be accessed at https://www.watchlistnews.com/lathrop-investment-management-corp-acquires-shares-of-1636-eli-lilly-and-co-lly/2985529.html.

About Eli Lilly And Co

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates in two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for the treatment of diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions.

Featured Article: What is cost of equity?

Want to see what other hedge funds are holding LLY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Eli Lilly And Co (NYSE:LLY).

Institutional Ownership by Quarter for Eli Lilly And Co (NYSE:LLY)

Receive News & Ratings for Eli Lilly And Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eli Lilly And Co and related companies with MarketBeat.com's FREE daily email newsletter.